comparemela.com

Latest Breaking News On - Fusn - Page 8 : comparemela.com

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) CEO Sells $19,162.00 in Stock

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Rating) CEO John Valliant sold 2,600 shares of the company’s stock in a transaction on Monday, April 11th. The shares were sold at an average price of $7.37, for a total value of $19,162.00. Following the completion of the sale, the chief executive officer now owns 358,379 shares of […]

John-valliant
Fusion-pharmaceuticals-inc
Geode-capital-management
Securities-exchange-commission
Goldman-sachs-group-inc
Zacks-investment-research
Sectoral-asset-management-inc
Nasdaq
Fusion-pharmaceuticals-get-rating
Alphacentric-advisors
Quarter-for-fusion-pharmaceuticals
Fusion-pharmaceuticals

Fusion Pharmaceuticals (NASDAQ:FUSN) Releases Earnings Results, Beats Expectations By $0.06 EPS

Fusion Pharmaceuticals (NASDAQ:FUSN – Get Rating) issued its quarterly earnings results on Thursday. The company reported ($0.40) EPS for the quarter, beating analysts’ consensus estimates of ($0.46) by $0.06, MarketWatch Earnings reports. FUSN opened at $7.35 on Friday. Fusion Pharmaceuticals has a 52-week low of $4.09 and a 52-week high of $12.47. The business’s 50-day […]

John-valliant
Morgan-stanley
Fusion-pharmaceuticals-inc
Geode-capital-management
Goldman-sachs-group-inc
Earnings-history-for-fusion-pharmaceuticals
Zacks-investment-research
Fusion-pharmaceuticals-company-profile-get-rating
Fusion-pharmaceuticals
Millennium-management
Get-rating
Marketwatch-earnings

-$0.47 EPS Expected for Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) This Quarter

Analysts expect Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Rating) to announce earnings per share of ($0.47) for the current fiscal quarter, according to Zacks. Zero analysts have issued estimates for Fusion Pharmaceuticals’ earnings. The highest EPS estimate is ($0.36) and the lowest is ($0.51). Fusion Pharmaceuticals posted earnings of ($0.32) per share in the same […]

John-valliant
Morgan-stanley
Fusion-pharmaceuticals-inc
Securities-exchange-commission
Goldman-sachs-group-inc
Zacks-investment-research
Sectoral-asset-management-inc
Nasdaq
Fusion-pharmaceuticals-get-rating
Fusion-pharmaceuticals
Millennium-management
Get-rating

Detailed text transcripts for TV channel - MSNBC - 20161009:00:53:00

now that fedex has helped us we could fusn bigger issues, like our psive aggressive environment. we re not passive aggressive. hey, hey, hey, there are no bad suggestions here. no matter how lame they are. well said, ann. i ve always admired how you just say what s in your head, without thinking. very brave. good point ted. you living prf that looks aren t everything. thank you. welcome. so, fedex helped simplify our e-commerce business d this inot a passiveaggressive. i ju wanted to say, you guys are doing a great job.

Matter
Fusn
Fedex
Suggestions
Psive-aggressive-environment
Ann
Well-said
Guys
Head
Inota-passiveaggressive
Thinking
Arent-everything

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.